Adoptive transfer of naturally occurring or cultured polyclonal CD4+CD25+ regulatory T cells has been shown to exert potentially therapeutic effects on autoimmune diseases in many animal models [1,2]. This evidence concerns the gene CD4 and autoimmune disease.